15 results
·
21ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
MODIFICATION TO PROVIDENT HIP SYSTEM
FDA 510(k)
FDA Class 2
·Orthopedic
DURA-CUF
FDA UDI
GE MEDICAL SYSTEMS INFORMATION TECHNOLOGIES, INC.·00840682110495·DURA-CUF, THIGH, 2 TB SCREW, 38 - 50 CM, SINGLE
GRADIA®
FDA UDI
Gc America Inc.·D0470027961·GRADIA® DIRECT X Syringes -1 syringe 2.7 mL/5 g...
GRADIA®
FDA UDI
Gc America Inc.·14548161322355·GRADIA® DIRECT X Syringes -1 syringe 2.7 mL/5 g...
MAGIC MOBILITY 4 X 4 WHEELCHAIR
FDA 510(k)
FDA Class 2
·Physical Medicine
GYROSCAN INTERA (R7.5)
FDA 510(k)
FDA Class 2
·Radiology
VARISOFT
FDA Adverse Event
Malfunction
·UNOMEDICAL A/S·Product code FPA·July 17, 2025
PROMUS ELEMENT ¿
FDA Adverse Event
Malfunction
·BOSTON SCIENTIFIC - GALWAY·Product code NIQ·March 13, 2013
VOYAGER NC CORONARY DILATATION CATHETER
FDA Adverse Event
Malfunction
·AV-TEMECULA-CT·Product code LOX·February 28, 2011
CELL DYN SAPPHIRE ANALYZER
FDA Adverse Event
Malfunction
·ABBOTT DIAGNOSTICS DIVISION/CELL DYN·Product code GKZ·February 26, 2008
Stryker End Cap T2 Tibia +10 mm Catalog Number: 18220010S - Product Usage: Stryker implants are single use devices intended for the temporary fixation, correction or stabilization of bones.
FDA Enforcement
Class II
·Terminated·Stryker GmbH·June 24, 2020
SMR CTA HUMERAL HEAD 46 MM
FDA Adverse Event
Malfunction
·LIMACORPORATE SPA·Product code HSD·June 17, 2020
EVOLUT FX PLUS VALVE
FDA Adverse Event
Malfunction
·MEDTRONIC HEART VALVES DIVISION·Product code NPT·March 3, 2025
Boston Scientific/Cameron Health SQ-RX Model 1010 subcutaneous pulse generators. The S-ICD System is intended to provide therapy for the treatment of life-threatening ventricular tachyarrhythmias.
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·March 27, 2013
CADD-Solis Ambulatory Infusion Pumps, Model 2100. Intended for the following uses: Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024